CONCLUSIONS: Soy intake may be associated with a small reduction in breast cancer risk. However, this result should be interpreted with caution due to ... BJ Trock,HC Leena,C Robert - 《J Natl Cancer Inst》 被引量: 863发表: 2006年 Population-based case-control study of soyfood intake ...
The Pentagon's 'Small Business Strategy', released in January this year, called for the creation of the working group to explore ways to help small businesses mitigate FOCI risks. The document also recommended the DoD offer education and training to make small businesses aware of such threats ...
Benitez K, Malin B (2010) Evaluating re-identification risks with respect to the HIPAA privacy rule. J Am Med Inform Assoc 17(2): 169–177. Blumenstein BA (1989) The relational database model and multiple multicenter clinical trials. Control Clin Trials 10(4): 386–406. Bulusu VR, Full...
A balance between the benefits and risks of therapy versus those associated with untreated disease is often dependent on a joint decision between the physician and the patient. Patients with SCLC commonly present with shortness of breath or chest pain that often rapidly improve following initial ...
The long-term health effects may arise from residential exposure to large-scale pesticide applications in their vicinity12. A prior study demonstrated that breast cancer risks were significantly associated with residents living in a 1-mile radius of organophosphate pesticide disposing sites13. A geograph...
IMpower010 was the first phase III trial to compare adjuvant immunotherapy with standard therapy for resected stage IB–IIIA NSCLC [24]. After adjuvant chemotherapy, atezolizumab group was associated with a significantly longer DFS compared with supportive care group. The risks of recurrence and death...
[37] in malignancies such as breast cancer [48], nasopharyngeal carcinoma [49], and NSCLC [50]. Cytokines and chemokines are critical in regulating T-cell recruitment and the overall cellular composition of the tumor microenvironment [51,52,53]. Activated RhoA leads to the formation of stress...
Finally, in the recent Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting, as regards the overall risk–benefit analysis of poziotinib, the committee ultimately voted 9 to 4 that the current benefits do not outweigh its risks. Given these considerations, ...
suggesting that SFX shows a strong inhibitory effect on the secretion of sEV from breast cancer cells (Fig.1band Supplementary Fig.3c). Consistent with this reduction of secreted sEV, the amounts of sEV proteins, such as CD9, filotillin-1, Alix, Tsg101, and CD63, were decreased (Supplem...
ED is also closely correlated with prognosis and survival outcomes in patients with cancer, as those experiencing depression and/or anxiety symptoms have elevated risks of recurrence and heightened mortality rates14,28. However, the screening and monitoring of ED are often disregarded and are not inc...